Source: British Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: FARMACOCINÉTICA, DIABETES MELLITUS, DOR, HIPERGLICEMIA, FARMACOLOGIA CLÍNICA
ABNT
COSTA, Ana Carolina Conchon et al. Population pharmacokinetics of gabapentin in patients with neuropathic pain: lack of effect of diabetes or glycaemic control. British Journal of Clinical Pharmacology, v. 87, n. 4, p. 1981-1989, 2021Tradução . . Disponível em: https://doi.org/10.1111/bcp.14594. Acesso em: 15 nov. 2024.APA
Costa, A. C. C., Benzi, J. R. de L., Yamamoto, P. A., Freitas, M. C. F. de, Paula, F. J. A. de, Zanelli, C. F., et al. (2021). Population pharmacokinetics of gabapentin in patients with neuropathic pain: lack of effect of diabetes or glycaemic control. British Journal of Clinical Pharmacology, 87( 4), 1981-1989. doi:10.1111/bcp.14594NLM
Costa ACC, Benzi JR de L, Yamamoto PA, Freitas MCF de, Paula FJA de, Zanelli CF, Lauretti GR, Moraes NV. Population pharmacokinetics of gabapentin in patients with neuropathic pain: lack of effect of diabetes or glycaemic control [Internet]. British Journal of Clinical Pharmacology. 2021 ; 87( 4): 1981-1989.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1111/bcp.14594Vancouver
Costa ACC, Benzi JR de L, Yamamoto PA, Freitas MCF de, Paula FJA de, Zanelli CF, Lauretti GR, Moraes NV. Population pharmacokinetics of gabapentin in patients with neuropathic pain: lack of effect of diabetes or glycaemic control [Internet]. British Journal of Clinical Pharmacology. 2021 ; 87( 4): 1981-1989.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1111/bcp.14594